Announcement of TTY Biopharm's unaudited income information in Feb 2020
2020.3.12
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2020/03/12 | Time of announcement | 14:05:47 |
| Subject | Announcement of TTY Biopharm's unaudited income information in Feb 2020 | ||||
| Date of events | 2020/3/12 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2020/03/12 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $315,671 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $56,833 thousands, and a consolidated income before tax of $66,363 thousands in Feb 2020; net income attributed to stockholders of the company was $51,935 thousands; EPS is $0.21. Year-to-date consolidated net sales was $685,764 thousands (in NT dollars; unaudited), a consolidated operating profit was $163,195 thousands and consolidated income before tax was $190,336 thousands until Feb 2020; year-to-date net income attributed to stockholders of the company was $148,173 thousands; EPS is $0.60. 6.Countermeasures:N/A 7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||